Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 4Sanofi
02 1BioMarin Pharmaceutical
Reset all filters
01 1Concentrate For Infusion Solution
02 1Concentrate For Solution For Infusion
03 1INJ
04 1SOLUTION
05 1VIAL
Reset all filters
01 1Approved
02 1Authorized
03 1Originator
04 1Schedule D
05 1Blank
Reset all filters
01 3ALDURAZYME
02 1Aldurazyme
03 1Aldurazyme,
Reset all filters
01 1Canada
02 1South Africa
03 1Spain
04 1Sweden
05 1USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Aldurazyme
Dosage Form : Concentrate For Solution For Infusion
Dosage Strength : 100U/ml
Packaging :
Approval Date : 10/06/2003
Application Number : 20030610000026
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Schedule D
Registration Country : Canada
Brand Name : ALDURAZYME
Dosage Form : SOLUTION
Dosage Strength : 0.58MG/ML
Packaging : 5.3ML
Approval Date :
Application Number : 2254506
Regulatory Info : Schedule D
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : ALDURAZYME
Dosage Form : INJ
Dosage Strength : 40D units
Packaging : 5X1MG/5ML
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Aldurazyme,
Dosage Form : Concentrate For Infusion Solution
Dosage Strength : 100UNIT
Packaging :
Approval Date : 2003-06-24
Application Number : 03253001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : USA
Brand Name : ALDURAZYME
Dosage Form : VIAL
Dosage Strength : 2.9MG/ML
Packaging :
Approval Date :
Application Number : 125058
Regulatory Info :
Registration Country : USA